About MicroGenDX

Mission Statement

Our mission at MicroGenDX is to improve clinical outcomes by offering clinicians and their patients the most informative and impactful microbial diagnostic tests that science can provide.

Bringing desperately needed advances in diagnostics to providers and patients

Southwest Regional PCR first offered a 2-step process combining qPCR and NGS to identify microbes in 2010 under the commercial name PathoGenius. In 2017, the laboratory was purchased by Rick Martin, head of commercialization for this testing, and rebranded as Southwest Regional PCR dba MicroGenDX. Since that new branding and leadership, the laboratory has grown in scale and reach for physicians, specialties and infection types – both nationally and internationally.

A global leader in NGS diagnostics of infection

MicroGenDX laboratory has run over 500,000 next-gen DNA sequencing tests at our state-of-the-art, CAP-accredited, CLIA-licensed molecular diagnostic facility. Our advanced instrumentation, including Illumina Miseq sequencers, provides the industry’s most informative microbial diagnostics for ENT/AFB, microbiology laboratories, orthopedics, urology, wound care, podiatry, pulmonary, ExPlants, periodontal, podiatry/nail, OB-GYN, infectious disease, and other medical specialties. Our laboratory is supported by a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. MicroGenDX employs over 200 passionate employees, with a leadership model that swiftly adapts to global health concerns and new technologies. We want to help as many people as possible with microbial identification of challenging infections.

Click Below to View Our Licenses

Licenses

Southwest Regional PCR Laboratory LLC dba MicroGenDX® Laboratory is a CAP accredited, CLIA licensed clinical diagnostic laboratory providing physicians and their patients with the most advanced molecular based microbial testing available. The laboratory utilizes molecular diagnostics and specializes in Next Generation DNA Sequencing technologies to identify pathogenic microbes within patient samples. MicroGenDX® is currently licensed to provide these services in 49 of the 50 states, with New York being the exception. Most states do not require additional licensure beyond CAP accreditation and CLIA licensing.

Click links below to see current images of our licenses, or contact us with specific questions regarding your location.

CAP License 2023

California State License

Maryland State License

Maryland State License

Pennsylvania State License

Pennsylvania State License

Rhode Island State License

Rhode Island State License

Translate »
Shopping Cart
There are no products in the cart!
Continue Shopping
0